GO
Loading...

Cramer's stocks to watch: AGN & VRX

Monday, 21 Jul 2014 | 8:53 AM ET

CNBC's Jim Cramer shares his thoughts on the feud between Allergan and Valeant, and weighs in on how a slowdown in Europe would likely impact U.S. markets.